Cargando…
Phenotypic selection through cell death: stochastic modelling of O-6-methylguanine-DNA methyltransferase dynamics
Glioblastoma (GBM) is the most aggressive malignant primary brain tumour with a median overall survival of 15 months. To treat GBM, patients currently undergo a surgical resection followed by exposure to radiotherapy and concurrent and adjuvant temozolomide (TMZ) chemotherapy. However, this protocol...
Autores principales: | Lasri, Ayoub, Juric, Viktorija, Verreault, Maité, Bielle, Franck, Idbaih, Ahmed, Kel, Alexander, Murphy, Brona, Sturrock, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428254/ https://www.ncbi.nlm.nih.gov/pubmed/32874597 http://dx.doi.org/10.1098/rsos.191243 |
Ejemplares similares
-
Transcriptional CDK inhibitors, CYC065 and THZ1 promote Bim-dependent apoptosis in primary and recurrent GBM through cell cycle arrest and Mcl-1 downregulation
por: Juric, Viktorija, et al.
Publicado: (2021) -
Marizomib sensitizes primary glioma cells to apoptosis induced by a latest-generation TRAIL receptor agonist
por: Boccellato, Chiara, et al.
Publicado: (2021) -
Cyclin-dependent kinase inhibitors in brain cancer: current state and future directions
por: Juric, Viktorija, et al.
Publicado: (2020) -
O6-methylguanine-DNA methyltransferase activities in biopsies of human melanoma tumours.
por: Egyházi, S., et al.
Publicado: (1995) -
Regulation of O6-methylguanine-DNA methyltransferase by methionine in human tumour cells.
por: Kokkinakis, D. M., et al.
Publicado: (1997)